Kevin K Buckbee sold $3.9M of AbbVie (ABBV)

Executed Feb 26 2025, disclosed Feb 28 2025, 2 days later.

Value, as filed

$3.9M

18,944 sh across 2 lots

Executed

Feb 26 2025

the trade date, as filed

Disclosed

Feb 28 2025

2 days after the trade

Return, 21 sessionsiFrom the disclosed entry session; derived

–

purchases only

Returns are measured on stock purchases only.

The filer

KB Kevin K Buckbee SVP, CONTROLLER profile →

Kevin K Buckbee (SVP, CONTROLLER) filed 2 Form 4 reports in the past 24 months (0 purchases, 2 sales), most often in AbbVie Inc. (ABBV). The largest single filing was $3.9M of ABBV (18,944 sh across 2 lots, as filed), executed Feb 26 2025.

The name

ABBV AbbVie Inc. ABBV · Healthcare · 41 filings in 24 months ticker →

Healthcare · AbbVie Inc., a research-based biopharmaceutical company, engages in the research and development, manufacturing, commercializing, and sale…

More Healthcare filings→ Insider filings, newest first→ View the original filing at www.sec.gov→

Other filings by Kevin K Buckbee in ABBV

ABBVSALE AbbVie Inc. $310K
1,800 sh × $172.24
Exec Dec 16 2024
Filed Dec 18 2024 · 5:30 PM ET